Oncolytic Virus Immunotherapy Market: How Is Virus-Based Cancer Therapy Opening a New Treatment Frontier?
Virus-based cancer therapy — the use of engineered or naturally selective viruses to attack tumor cells while stimulating immune response — is the defining scientific and commercial force behind the oncolytic virus immunotherapy market. This category sits at the frontier of oncology because it combines direct tumor destruction with immune activation, creating a treatment model that...
0 Commentarios 0 Acciones 6 Views 0 Vista previa